Vertical transmission of human T-lymphotropic virus type I (HTLV-I) depends primarily on breast-feeding; substitution of bottle-feeding has reduced the transmission rate from 20% in breast-fed children to 3% among bottle-fed. To determine the correlates of transmission for long breast-feeding (> or = 6 mo), short breast-feeding (< 6 mo), and bottle-feeding mothers, the antibody titers of transmitter (T) mothers and non-transmitter (nT) mothers were analyzed by using synthetic and recombinant epitopes representing the immunodominant epitopes of gag (Gag1a, r24), env (Env1/5, MTA1, RE3), and tax (Tax8/22-24) proteins. Seroreactivity to gag and tax epitopes was not significantly different except for anti-r24 antibody titer, which was significantly higher among T-mothers (geometric mean 134) when compared with nTmothers (62) in the long-feeding group (P < 0.001). Profiles of antibody titers against env epitopes were different. Within the long-feeding group, Env1/5, MTA1, and RE3 titers were significantly higher among T-mothers (258, 1,476, and 738, respectively) when compared with nT-mothers (106, 279, and 320, respectively) (P < 0.01 for all three epitopes). In contrast, within the bottle-feeding group, antibody titers to Env1/5 (269) and RE3 (418) among nT-mothers were significantly higher than those among T-mothers (80 and 113, respectively) (P < 0.01). These data confirm that high-titered anti-HTLV-I antibodies in the long-feeding group correlate with milk-borne transmission of HTLV-I and, more importantly, imply that maternal […] 
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Volume 95, June 1995, 2920-2925 Human T-lymphotropic virus type I (HTLV-I)' is endemic in southwestern Japan, the Caribbean Islands, and certain parts of Africa and is etiologically linked with adult T cell leukemia/ lymphoma and HTLV-I-associated myelopathy (1, 2) . The major routes of transmission for HTLV-I include sexual contact, blood transfusion, and mother to child (1, 3) . Seroepidemiologic studies of pregnant women and their children, as well as oral inoculation of carrier mothers' breast milk into common marmosets, indicates that breast-feeding plays an important role in the transmission of HTLV-I (4, 5) . In 1987, the ATL Prevention Program (APP) was initiated in Nagasaki, Japan, to determine whether screening and counseling of pregnant women could prevent transmission of HTLV-I by breast-feeding (6) .
Follow-up studies have shown that 20% of breast-fed children and only 3% of bottle-fed children born to HTLV-I-carrier mothers become infected (7, 8) . The observation that some breast-feeding and non-breast-feeding carrier mothers transmit HTLV-I while others do not implies that there may be mechanisms other than feeding that affect the transmission of HTLV-I from mother to child.
Several maternal risk factors for mother-to-child transmission of HTLV-I have been proposed: these include high levels of HTLV-I-positive lymphocytes in breast milk (9, 10) , high proviral load in peripheral blood (11) , high titer of anti-HTLV-I antibody (12) , and anti-tax antibodies (13, 14) . However, these studies on antibody titers have not identified the specific epitopes within the HTLV-I genome that might correlate with mother-to-child transmission. Thus, analysis of maternal HTLV-I antibodies directed against various antigens coded for by the HTLV-I genome may provide clues as to their potential use as markers for mother-to-child transmission, or alternatively, a protective role of these antibodies.
The APP cohort provided us a unique opportunity to assess the relationship between antibody reactivities and HTLV-I transmission. In the search for possible associations between the presence of specific antibodies and mother-to-child transmission of HTLV-I, we analyzed the antibodies in sera of mothers who transmitted HTLV-I (transmitter; T-mothers), and mothers who did not (non-transmitter; nT-mothers), using various peptides and recombinant proteins representing the immunodominant epitopes of HTLV-I. Our results indicate that hightitered maternal env antibodies are associated with transmission in long-term ( 2 6 mo) breast-fed children and that high-titered maternal antibodies to certain epitopes of external glycoproteins appear to be protective in bottle-fed children. 2920 Hino et al.
Methods
APP. Nagasaki Prefecture, one of 47 prefectures in Japan, is located in southwestern Japan on the island of Kyushu and has a population of -1.5 million. APP was implemented in this prefecture in 1987. Informed consent was obtained from each mother, and the study was approved under the guidelines of Nagasaki University. Pregnant women were offered serologic testing for HTLV-I, and infected women were counseled to refrain from breast-feeding. Since 1987, -15,000 women, representing > 85% of all pregnant women in the prefecture, have been screened annually. The HTLV-I prevalence in this group is 4%. As of December 1992, > 3,000 seropositive mothers were enrolled in the study.
At enrollment and thereafter, blood samples were taken from mothers in the last trimester of each pregnancy. After delivery, mothers were requested to bring their newborns to one of 17 designated pediatric units in the prefecture at 6, 12, 18, 24, and 36 mo of age. Approximately one-half of the mothers showed up for follow-up testing; on these visits information on breast-feeding was collected. Only children with a serum sample taken at -18 mo were considered eligible for purposes of classifying their mothers as T-mothers or nT-mothers. As of December 1992, records were available for 1,253 such children born to 889 mothers. In addition, 98 children up to 13 yr old, born to the same mothers before APP, had also been studied. Information on their breast-feeding status was also obtained.
Serologic testing for HTLV-I. Serum specimens from all participating subjects (mothers and children) were tested by gelatin particle agglutination assay (Fuji-Rebio, Tokyo, Japan) at commercial laboratories. All positive and indeterminate samples were sent to the Department of Bacteriology, Nagasaki University School of Medicine, where they were tested by particle agglutination and by an indirect immunofluorescence assay that used a mixture of MT-2 and CEM cells. Serum specimens with positive results in both assays were scored positive; those with positive results in one assay, or with indeterminate results in either assay, were tested further by immunoblot (15) .
To confirm the specificity of serologic tests, randomly selected specimens from 30 seropositive mothers and 26 seropositive children (2 18 mo old) were tested at the Centers for Disease Control and Prevention by a modified Western blot assay incorporating recombinant env proteins (HTLV 2.3; Genelabs Diagnostics Inc., Redwood, CA) (16) . A serum specimen was designated HTLV-I/II-positive if antibody reactivity was detected to gag p24 and env r2le or rgp46. All specimens that were confirmed to be HTLV-I/L1 positive in the APP were also positive at the Centers for Disease Control and Prevention.
Selection of HTLV-I-infected mothers for the study. Mothers were selected based on the presence of infection in one or more of their children (transmitters) or absence of infection in all eligible children (non-transmitters). All T-mothers whose blood samples were available in frozen stock were included in the study. The T-mothers were further classified based on the feeding history of the child: breast-fed for 2 6 mo (long-feeding), or for < 6 mo (short-feeding), or bottle-fed. One mother who transmitted HTLV-I to both a long-feeding and a bottlefed child was deleted from the study.
Many nT-mothers had eligible children in different feeding categories because of the implementation of APP. Mothers with more than one eligible breast-fed child were classified according to the child with the longest breast-feeding history. nT-mothers were selected using computer-generated random numbers so that the ratio of nT-to T-mothers in each feeding category would be -1.5:1.
Maternal antibodies to synthetic peptides and recombinant proteins.
The synthetic peptides derived from the gag (Gag-la'""7, PPSSPT- (20) . A whole viral lysate spiked with recombinant transmembrane protein (r2le) of HTLV-I was also included to determine the antibodies to whole virus proteins (21) . Antibodies to these synthetic peptides and recombinant proteins were determined as described previously (18, 19) . Seropositivity was defined as any value greater than the mean of the normal controls + 2 standard deviations. All specimens were coded without knowledge of the mother's category. Statistical analysis. Analysis proceeded using six categories of mothers, according to transmitter/non-transmitter and feeding status. Each mother was included in only one category. Antibody titers were expressed by reciprocals of the highest dilution that gave positive results in the Envl/5, MTA1, RE3, and r2le-spiked HTLV-I assays after 2-fold dilutions starting from 1:20. Assays of Gag-la, r24, and Tax8/22-24 assays were performed at a dilution of 1:20. Antibody titers in these assays were computed from a dilution curve of pooled standard positive sera. For calculation, negative sera were scored as one tube earlier than the first dilution (1:10), and overscaled ones were scored as the last dilution. Antibody titers were converted into logarithms for computation, and the geometric mean and 95% confidence intervals (determined by twice the standard deviation) were calculated back into linear scale. Statistical analyses were performed after all the immunological data were obtained by using nonparametrical analysis of variance by the Bonferroni/Dunn method.
Results
Classification ofHTLV-I-seropositive mothers. Of 889 mothers whose children were tested at the ages of at least 2 18 mo, we selected 169 mothers, including 66 T-mothers and 103 randomly sampled nT-mothers. All mothers were of Japanese descent. These mothers were further categorized based on the feeding history. Of the 66 T-mothers, 32 breast-fed their babies for 2 6 mo (long-feeding), 12 breast-fed for < 6 mo (short-feeding), and 22 bottle-fed their babies (Table I) . Of the 103 nT-mothers, 56 were in the long-feeding category, 19 were in the shortfeeding category, and 28 were in the bottle-feeding category.
The intervals between sampling of the mother and birth of the child were greater in breast-feeding than in bottle-feeding mothers because of inclusion of mothers who breast-fed older children. However, within each feeding category, the ages of the mothers and the intervals between sample of the mother and birth of the child in T-and nT-groups were highly comparable (Table I) .
Comparison ofmaternal antibody levels in the long-feeding group. The seroreactivity and antibody titers were compared in T-and nT-mothers using whole virus proteins spiked with r21e protein (HTLV-I) (Table II) . Serum specimens from all mothers, except for one nT-mother, reacted in the assay. Comparison of anti-HTLV-I titers demonstrated significantly higher levels among T-mothers (mean: 944; 95% CI: 80-11,092), as compared with nT-mothers (mean: 385; CI: 30-4,966) (P = < 0.001) (see Fig. 2 ). The antibody reactivities to gag Fig. 2 ).
Comparison ofmaternal antibody levels in the short-feeding group. Analysis of maternal seroreactivity within the short-feeding group revealed no significant difference between the T-and nT-groups in either the whole virus protein assay or any of the epitope-based assays (Table II) . Similarly, analysis of antibody titers in the short-feeding group did not reveal any differences 10 100 1000 10000 10 100 100 Antibody titer and could be attributed to the fact that T-mothers in this category represent both breast-feeding and non-breast-feeding-related transmission (22) .
Comparison of maternal antibody levels in the bottle-feeding group. Overall seroreactivity to HTLV-I, gag and tax epitopes, and the titers to gag epitopes were similar in T-and nTgroups (Table II) . Although the titers to HTLV-I were higher in nT-mothers (mean: 640; CI: 97-4,227) than in T-mothers (mean: 374; CI: 32-4,355), this difference did not reach statistical significance.
Seroreactivity to env epitopes (MTA1, RE3) was 100% in both groups; however, seroreactivity to Envl/5 was significantly higher among nT-mothers (28/28; 100%) than T-mothers (16/22; 73%) (P = 0.01). Analysis of anti-Envl/5 and RE3 titers demonstrated significantly higher levels among nTmothers (mean: 269; CI: 30-2,399, and mean: 418; CI: 33-5,309, respectively) than T-mothers (mean: 80; CI: < 20-2,449; and mean: 113; CI: < 20-2,767, respectively) (P = 0.002 and P < 0.001, respectively) (Table H and Fig. 2 ). Anti-MTAl titers were also higher in nT-mothers (mean: 693, CI: 51-9,441) than in T-mothers (mean: 453; CI: < 20-10,715), but the difference was not statistically significant. Of the 33 T-mothers originally in the long-feeding group, 20 had children who were bottle-fed and had samples available at > 18 mo. One of these mothers (deleted from the study) also transmitted infection to a bottle-fed child; her HTLV-I, Envl/5, MTA1, and RE3 titers were 160, 40, 320, and 320, respectively. Of the 22 T-mothers included in the bottle-feeding group, only one also had a child who was long-term breast-fed and had a specimen at 18 mo; this child was uninfected, and the mother's HTLV-I, Envl/5, MTA1, and RE3 titers were 80, 80, 80, and 40, respectively.
Discussion
While mother-to-child transmission is the major route of transmission of HTLV-I in endemic areas (3) (4) (5) , little is known about the immune responses that might affect such transmission. In this investigation, we have elucidated the serological basis for maternal immunity as it relates to either infectivity or protection from vertical transmission. We have examined this question by measuring specific binding of maternal serum samples to various immunodominant epitopes representing both the structural and regulatory proteins of HTLV-I (18) (19) (20) (21) . By using the model of mother-to-child transmission of HTLV-I infection, we have demonstrated that high antibody titers to HTLV-I and several epitopes from the envelope protein are associated with transmission to long-term breast-fed babies. We also have established an association between maternal antibodies to selected epitopes of external glycoproteins, in particular EnvI /5 and RE3, and absence of infectioh in bottle-fed children.
There are some limitations in this study regarding classification of mothers. It is possible that the nT categories included mothers who would have been found to transmit HTLV-I if they had more children with serum specimens available at 2 18 mo of age. However, such misclassification would decrease the difference between T-and nT-mothers. Another limitation was that nT-mothers who breast-fed an eligible child were so classified even if they bottle-fed younger eligible children. 26 such mothers were included in breast-feeding categories. However, addition of these 26 nT-mothers to the 28 nT-mothers in the bottle-feeding category still resulted in significantly higher env antibody titers in nT-versus T-mothers in the bottle-feeding category (data not shown). In the breast-feeding category, we included mothers whose classification was based on children born before the APP began. When such cases were nT-mothers, we cannot confirm that the mothers were carriers during these pregnancies. However, among 852 mothers who had also been tested in an earlier pregnancy, only 4 were seronegative at the earlier date. Thus, it is likely that the vast majority of, if not all, of these mothers were already infected during these earlier pregnancies. We also repeated our analyses, limiting them to mothers whose classification was based on children born during the APP. This resulted in a marked reduction in numbers of long-feeding mothers, and, in this group, T-mothers had higher env titers than nT-mothers in only the MTA assay (P = 0.03); however, similar trends were also observed in the Envi /5, RE3, and HTLV-I assays (data not shown). The numbers of bottlefeeding mothers and the results in this group were unchanged.
Analysis of anti-HTLV-I titers provided us a tool to determine the overall antibody status of T-and nT-mothers in all three feeding categories, and analysis of immunodominant regions within gag, env, and tax allowed us to localize the regions that correlate with transmission or protection. The overall percent reactivities to gag and env epitopes were similar to those in previous reports ( 16, 17) . However, the seroreactivity to Tax peptides was significantly lower (8-32%) than that previously reported for asymptomatic carriers from the United States (62%) (19) . Although the reason for the lower reactivities is not known, it could be related to sequence variations in this immunogenic region of tax, such as those found in a Melanesian isolate of HTLV-I (23).
Our finding of higher antibody titers to HTLV-I in T-mothers than nT-mothers in the long-feeding group corroborates previous reports in which high anti-HTLV-I titers were associated with increased frequency of mother-to-child transmission in long-fed babies (12, 24) . The high-titered anti-HTLV-I presumably reflects high concentration of infected cells in peripheral blood as evidenced by high proviral load (25) . At the epitope level, transmitters had significantly higher levels of antibodies to env epitopes, with no difference in gag and tax epitopes. These results corroborate previous results in which hightitered antibodies to env epitope sp4al, which overlaps with the env epitopes tested here, were shown to correlate with a high risk of transmission in breast-fed babies (24) . Our results further suggest that the COOH-terminal region of the external glycoprotein correlates with transmission. Taken together, these data imply that high-titered anti-HTLV-I antibodies, particularly those directed against the envelope protein, are associated with mother-to-child transmission, if the mother breast-feeds her child for 2 (29) .
If high-titered anti-env antibodies are protective against infection in bottle-fed children, how are they also related to increased transmission of HTLV-I from mother to child in longfed babies? Previous study has shown that children born to seropositive carrier mothers passively acquire maternal antibodies prenatally; levels of these maternal antibodies decline over 3-6 mo and disappear at 6-9 mo of age (30) . While the babies in the long-feeding group would still be breast-feeding on carrier mothers and ingesting HTLV-I-infected lymphocytes from the breast milk, the passively acquired high-titered anti-env antibodies would gradually disappear from circulation. This continuous ingestion of HTLV-I-infected lymphocytes could lead to HTLV-I infection in the babies (9) . Indeed, lymphocytefacilitated infection of gut-epithelium has been demonstrated in vitro (31) . We therefore believe that high-titered anti-HTLV-I in T-mothers reflects a high proviral load that, in long-term breast feeders, results in increased probability of transmission when passively acquired maternal antibodies have disappeared from circulation.
This report is the first to suggest that antibody titers against HTLV-I are associated with vertical transmission of HTLV-I in both milkborne and non-milkborne pathways, but in different directions. Specifically, non-milkborne transmission of HTLV-I was associated with lack of high-titered maternal antibodies to the env epitopes. Further study of the epitopes implicated herein may allow prediction of the humoral immune response that protects children from vertical transmission and may lead to immune-based therapy to prevent vertical transmission of HTLV-I.
